Login

Financial Snapshot

Revenue
TTM
$787.9M
Gross Margin
TTM
71.01%
Net Income
TTM
-$27.78M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
516.55%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$161.2M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$18.75M

Stock Price

Loading...
Market Cap: $3.4361 Billion

About iRhythm Holdings, Inc

iRhythm Holdings, Inc (NASDAQ: IRTC) is a cardiac monitoring company. The filing excerpts provided do not contain sufficient detail to describe its core business activity, revenue model, competitive position, geographic footprint, founding year, leadership, or financial metrics with the specificity required by source-grounded writing rules. All material facts have been omitted because they are not supported by the available filing excerpts.

Source: SEC 10-K, filed 2026-02-19

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Axonics, Inc. Enovis Corp QuidelOrtho Corp Inari Medical, Inc. Inspire Medical Systems Inc Integra Lifesciences Holdings Corp Omnicell Inc Tandem Diabetes Care Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support